Viewpoint Capital Management LLC Adma Biologics, Inc. Transaction History

Viewpoint Capital Management LLC

  • $177 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
BUY
$5.98 - $11.18 $29,900 - $55,900
5,000 Added 32.43%
20,416 $228,000
Q1 2024

Apr 16, 2024
BUY
$4.4 - $6.74 $10,630 - $16,283
2,416 Added 18.58%
15,416 $101,000
Q4 2022

Feb 13, 2023
BUY
$2.47 - $3.88 $32,110 - $50,440
13,000 New
13,000 $50,000
Q2 2022

Aug 11, 2022
BUY
$1.43 - $2.2 $18,590 - $28,600
13,000 New
13,000 $26,000

Others Institutions Holding ADMA

# of Institutions
312
Shares Held
184M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.16B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Viewpoint Capital Management LLC Portfolio

Follow Viewpoint Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viewpoint Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Viewpoint Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email